北美家禽疫苗市场预测至 2031 年 - 区域分析 - 按类型（肉鸡和蛋鸡）、技术（减毒活疫苗、灭活疫苗和重组疫苗）、剂型（液体疫苗、冻干疫苗和粉尘/粉状疫苗）、疾病（禽流感、沙门氏菌病、马立克氏病、传染性支气管炎 (IB)、传染性法氏囊病 (IBD)、新城疫等）、给药途径（饮用水 (D/W)、肌肉注射 (I/M)、皮下 (S/C) 等）和最终用户（家禽养殖场、兽医医院和家禽疫苗接种中心和诊所）

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

No. of Pages: 117    |    Report Code: TIPRE00023751    |    Category: Life Sciences

Explore in Your Language
English Arabic French German Italian Japanese Korean Spanish
North America Poultry Vaccines Market
Free Sample Buy Now
2023 年北美家禽疫苗市场价值为 7.0204 亿美元，预计到 2031 年将达到 13.2726 亿美元；预计 2023 年至 2031 年的复合年增长率为 8.3%。

家禽疾病患病率上升推动北美家禽疫苗市场发展

家禽生产通过鸡蛋和肉类产生不同类型的动物蛋白。随着家禽产量的增加，感染“禽病”等几种人畜共患疾病的可能性很高，这可能会导致巨大的经济损失，尤其是在发展中国家。例如，鸡更容易感染细菌、病毒、寄生虫和真菌。这些病毒爆发可导致新城疫、禽流感、传染性法氏囊病和其他家禽疾病。

下表列出了 2022 年加拿大各地哺乳动物中禽流感的疾病爆发情况。

哺乳动物禽流感病例

国家

家禽疾病

疾病爆发（2022 年）

加拿大

40

加拿大

H5N5

2

来源：世界动物卫生组织 2023 年

家禽疾病是导致雏鸡死亡的主要原因，也导致鸡的畜牧生产力下降。农民在传播人畜共患疾病时面临巨大的经济损失，对哺乳动物构成严重的健康风险。例如，家禽球虫病是全球最常见的疾病之一；它导致与死亡、体重减轻以及与预防和治疗控制相关的额外费用相关的巨大损失。根据 DSM 公司网站的数据，全球农民每年因鸡和禽类球虫病而面临 30 亿美元的经济损失。新城疫也被认为是一种经济代价高昂的疾病，给出口家禽产品的发展中国家的农民造成巨大的生产损失。

因此，家禽疾病的流行率上升导致巨大的经济损失，刺激了对家禽疫苗的需求，从而推动了市场的发展。

北美家禽疫苗市场概况

北美占家禽疫苗市场的大部分份额。在北美区域市场中，美国占最大份额，因为该国有顶级公司和提供疫苗接种服务的完善中心。上述事实是影响预测期内该地区市场增长的关键因素之一。

北美家禽疫苗市场收入及预测至 2031 年（百万美元）

北美家禽疫苗市场细分

北美家禽疫苗市场分为类型、技术、剂型、疾病、给药途径、最终用户和国家。

根据类型，北美家禽疫苗市场分为肉鸡和蛋鸡。肉鸡部分在 2023 年占据了更大的市场份额。

就技术而言，北美家禽疫苗市场分为减毒活疫苗、灭活疫苗和重组疫苗。减毒活疫苗部分在 2023 年占据了最大的市场份额。

按剂型，北美家禽疫苗市场分为液体疫苗、冻干疫苗和粉尘/粉末形式疫苗。 2023 年，液体疫苗部分占据最大市场份额。

根据疾病，北美家禽疫苗市场细分为禽流感、传染性支气管炎、马立克氏病、禽沙门氏菌病、传染性法氏囊病 (IBD)、新城疫等。禽流感部分在 2023 年占据最大市场份额。

就给药途径而言，北美家禽疫苗市场分为饮用水 (D/W)、肌肉注射 (I/M)、皮下 (I/S) 和其他。饮用水 (D/W) 部分在 2023 年占据最大市场份额。

根据最终用户，北美家禽疫苗市场细分为家禽养殖场和孵化场、兽医医院和家禽疫苗接种中心和诊所。 2023 年，家禽养殖场和孵化场占据了最大的市场份额。

按国家/地区划分，北美家禽疫苗市场分为美国、加拿大和墨西哥。2023 年，美国占据了北美家禽疫苗市场份额的主导地位。

Starkey Laboratories Inc.、Audina Hearing Instruments Inc、Sebotek Hearing Systems LLC、Earlens Corp、GN Store Nord AS、Cochlear Ltd、WS Audiology AS、Sonova Holding AG、Sonic Innovations Inc 和 Amplifon Hearing Health Care Corp. 是北美家禽疫苗市场的一些领先公司。

North America Poultry Vaccines Strategic Insights

Strategic insights for North America Poultry Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-poultry-vaccines-market-strategic-framework.webp
Get more information on this report

North America Poultry Vaccines Report Scope

Report Attribute Details
Market size in 2023 US$ 702.04 Million
Market Size by 2031 US$ 1,327.26 Million
Global CAGR (2023 - 2031) 8.3%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 类型
  • 肉鸡
  • 蛋鸡
By 技术
  • 减毒活疫苗
  • 灭活疫苗
  • 重组疫苗 剂型
By 给药途径
  • 饮用水
  • 肌肉注射
  • 皮下注射
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Boehringer Ingelheim International GmbH.
  • Zoetis Inc.
  • Phibro Animal Health Corp.
  • Dechra Pharmaceuticals PLC.
  • Elanco Animal Health Inc.
  • Merck KGaA.
  • Ceva.
  • Vaccinova AB.
    		•
    Get more information on this report

    North America Poultry Vaccines Regional Insights

    The regional scope of North America Poultry Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-poultry-vaccines-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - North America Poultry Vaccines Market

    • Boehringer Ingelheim International GmbH.
    • Zoetis Inc.
    • Phibro Animal Health Corp.
    • Dechra Pharmaceuticals PLC.
    • Elanco Animal Health Inc.
    • Merck KGaA.
    • Ceva.
    • Vaccinova AB.
    Frequently Asked Questions
    How big is the North America Poultry Vaccines Market?

    The North America Poultry Vaccines Market is valued at US$ 702.04 Million in 2023, it is projected to reach US$ 1,327.26 Million by 2031.

    What is the CAGR for North America Poultry Vaccines Market by (2023 - 2031)?

    As per our report North America Poultry Vaccines Market, the market size is valued at US$ 702.04 Million in 2023, projecting it to reach US$ 1,327.26 Million by 2031. This translates to a CAGR of approximately 8.3% during the forecast period.

    What segments are covered in this report?

    The North America Poultry Vaccines Market report typically cover these key segments-

  • 类型 (肉鸡, 蛋鸡)
  • 技术 (减毒活疫苗, 灭活疫苗, 重组疫苗) 剂型 (液体疫苗, 冻干疫苗, 粉状疫苗)
  • 给药途径 (饮用水, 肌肉注射, 皮下注射)

    • What is the historic period, base year, and forecast period taken for North America Poultry Vaccines Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Poultry Vaccines Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
    • Who are the major players in North America Poultry Vaccines Market?

    The North America Poultry Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Boehringer Ingelheim International GmbH.
  • Zoetis Inc.
  • Phibro Animal Health Corp.
  • Dechra Pharmaceuticals PLC.
  • Elanco Animal Health Inc.
  • Merck KGaA.
  • Ceva.
  • Vaccinova AB.
    • Who should buy this report?

    The North America Poultry Vaccines Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Poultry Vaccines Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Request Free Sample Buy Now
    north-america-poultry-vaccines-market